Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aileron Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ALRN
Nasdaq
8731
https://aileronrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aileron Therapeutics Inc
Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
- May 15th, 2024 9:13 pm
Down -36.29% in 4 Weeks, Here's Why Aileron Therapeutics (ALRN) Looks Ripe for a Turnaround
- May 7th, 2024 1:35 pm
Aileron Therapeutics to Present at Two Upcoming Investor Conferences
- May 6th, 2024 8:05 pm
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
- May 3rd, 2024 8:05 pm
Aileron reports data from cohort one of Phase Ib inhaled IPF treatment trial
- May 2nd, 2024 11:24 am
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
- May 1st, 2024 12:45 pm
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
- May 1st, 2024 12:30 pm
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Apr 15th, 2024 9:20 pm
Aileron Therapeutics Announces CEO Transition
- Mar 12th, 2024 12:00 pm
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
- Feb 15th, 2024 9:05 pm
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
- Feb 1st, 2024 9:30 pm
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
- Oct 31st, 2023 4:30 pm
Scroll